Allergan and tribe claim PTAB can’t decide on Restasis patents

13-03-2018

Allergan and tribe claim PTAB can’t decide on Restasis patents

bee32 / iStockphoto.com

Allergan and the Saint Regis Mohawk Tribe have argued that the Patent Trial and Appeal Board (PTAB) doesn’t have the jurisdiction to decide on the validity of patents concerning a dry-eye treatment while its recent decision is being appealed.


generics, Restasis, patent invalidation, Allergan, Saint Regis Mohawk Tribe, PTAB, IPR, sovereign immunity, US Court of Appeals for the Federal Circuit

LSIPR